According to different studies, wild-type p53 inhibits tumor angiogenesis by decreasing the levels of basic fibroblast growth factor (bFGF) and cyclooxygenase-2 (COX-2) in addition to VEGF [81]. Here, PTGS2 is linked to neoplasm.